CS Diagnostics files 8-K describing business and CS Protect Hydrogel product

CS DIAGNOSTICS CORP.

Filing provides general overview of CS Diagnostics Corp. as a medical distribution company.
Highlights CS Protect Hydrogel spacer gel for prostate cancer radiation therapy.
No specific financial results, contracts, approvals, or material events reported.
Lists company officers but no changes to leadership are disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.